Deerfield Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Deerfield Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,077,893	Closed	-$38.5M	–	236
2023 Q3	$38.5M	Hold	2,077,893	–	–	0.85%	32
2023 Q2	$23M	Buy	+2,077,893	New	+$29M	0.49%	43
2015 Q1	–	Sell	-60,393	Closed	-$9.42M	–	134
2014 Q4	$9.42M	Sell	60,393 -38,300	-39%	-$7.07M	0.34%	62
2014 Q3	$23.4M	Buy	+98,693	New	+$25.2M	0.85%	40

Deerfield Management's ICPT Position: Q4 2023 in Review

Deerfield Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 2,077,893 shares — an estimated $38.5M sold.

Deerfield Management first reported a position in ICPT in Q3 2014 and held it in 4 quarters. The position peaked at $38.5M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Deerfield Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Deerfield Management sold 2,077,893 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $38.5M.
Deerfield Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 4 quarters.
Deerfield Management's Intercept Pharmaceuticals, Inc. position peaked at $38.5M in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Deerfield Management's 13F filing for Q4 2023, filed 14 Feb 2024.